Document Detail


Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.
MedLine Citation:
PMID:  20413033     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: This study sought to assess the impact of continuous flow left ventricular assist devices (LVADs) on functional capacity and heart failure-related quality of life. BACKGROUND: Newer continuous-flow LVAD are smaller and quieter than pulsatile-flow LVADs. METHODS: Data from advanced heart failure patients enrolled in the HeartMate II LVAD (Thoratec Corporation, Pleasanton, California) bridge to transplantation (BTT) (n = 281) and destination therapy (DT) (n = 374) trials were analyzed. Functional status (New York Heart Association [NYHA] functional class, 6-min walk distance, patient activity scores), and quality of life (Minnesota Living With Heart Failure [MLWHF] and Kansas City Cardiomyopathy Questionnaires [KCCQ]) were collected before and after LVAD implantation. RESULTS: Compared with baseline, LVAD patients demonstrated early and sustained improvements in functional status and quality of life. Most patients had NYHA functional class IV symptoms at baseline. Following implant, 82% (BTT) and 80% (DT) of patients at 6 months and 79% (DT) at 24 months improved to NYHA functional class I or II. Mean 6-min walk distance in DT patients was 204 m in patients able to ambulate at baseline, which improved to 350 and 360 m at 6 and 24 months. There were also significant and sustained improvements from baseline in both BTT and DT patients in median MLWHF scores (by 40 and 42 U in DT patients, or 52% and 55%, at 6 and 24 months, respectively), and KCCQ overall summary scores (by 39 and 41 U, or 170% and 178%). CONCLUSIONS: Use of a continuous flow LVAD in advanced heart failure patients results in clinically relevant improvements in functional capacity and heart failure-related quality of life.
Authors:
Joseph G Rogers; Keith D Aaronson; Andrew J Boyle; Stuart D Russell; Carmelo A Milano; Francis D Pagani; Brooks S Edwards; Soon Park; Ranjit John; John V Conte; David J Farrar; Mark S Slaughter;
Related Documents :
14555553 - Aspirin does not adversely affect survival in patients with stable congestive heart fai...
12360173 - Septal q waves as an indicator of risk of mortality in elderly patients with chronic he...
21303423 - Management of asymptomatic hyperuricemia in patients with chronic kidney disease by jap...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  55     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-23     Completed Date:  2010-05-06     Revised Date:  2010-11-12    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1826-34     Citation Subset:  AIM; IM    
Copyright Information:
Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Affiliation:
Duke University Medical Center, Durham, NC 27710, USA. joseph.rogers@duke.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Equipment Design
Female
Heart Failure / physiopathology,  therapy*
Heart Ventricles
Heart-Assist Devices*
Humans
Male
Middle Aged
Quality of Life
Questionnaires
Walking / physiology
Comments/Corrections
Comment In:
J Am Coll Cardiol. 2010 Apr 27;55(17):1835-6   [PMID:  20413034 ]
Nat Rev Cardiol. 2010 Jul;7(7):360   [PMID:  20590000 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Oscillatory breathing and exercise gas exchange abnormalities prognosticate early mortality and morb...
Next Document:  Depression and the usefulness of a disease management program in heart failure: insights from the CO...